Platinum-Based Neoadjuvant Chemotherapy for Breast Cancer With BRCA Mutations: A Meta-Analysis.

Wang, Chang-Jun; Xu, Ying; Lin, Yan; Zhu, Han-Jiang; Zhou, Yi-Dong; Mao, Feng; Zhang, Xiao-Hui; Huang, Xin; Zhong, Ying; Sun, Qiang; Li, Cheng-Gang

Wang, Chang-Jun; Xu, Ying; Lin, Yan; Zhu, Han-Jiang; Zhou, Yi-Dong; Mao, Feng; Zhang, Xiao-Hui; Huang, Xin; Zhong, Ying; Sun, Qiang; Li, Cheng-Gang.

Afiliação

Wang CJ; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Xu Y; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Lin Y; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Zhu HJ; Department of Dermatology, University of California, San Francisco, CA, United States.
Zhou YD; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Mao F; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Zhang XH; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Huang X; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Zhong Y; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Sun Q; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Li CG; State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.

Front Oncol ; 10: 592998, 2020.

Article em En | MEDLINE | ID: mdl-33304851

Palavras-chave

BRCA gene; breast cancer; neoadjuvant chemotherapy; pathological complete response; platinum

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google